The US Department of Justice announced Friday that Pfizer has agreed in New York federal court to pay $59.7 million to ...

These four top dividend stocks offer dependable passive income streams and solid total return, and they are too cheap to ...

US pharma giant Pfizer on Saturday announced positive results from the Phase III BREAKWATER trial evaluating its Braftovi ...

Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX® ) and mFOLFOX6 ...

Dividend stocks can be a great way to boost your portfolio's growth potential or provide a form of passive income over the ...

Equities research analysts at Zacks Research upped their Q1 2026 earnings per share estimates for Pfizer in a report released ...

Pfizer (PFE) colorectal cancer therapy Braftovi as part of a drug combo indicates a favorable objective response rate in a ...

Pfizer (NYSE:PFE) has agreed to pay $59.7 million to resolve allegations that Biohaven Pharmaceuticals, acquired by Pfizer in ...

Pfizer (PFE) has agreed to pay nearly $60M to resolve allegations that its Biohaven unit paid kickbacks to induce ...

In 2022, pharmaceutical giant Pfizer (NYSE: PFE) became the first healthcare company to generate $100 billion in annual sales ...

Pfizer Inc. closed 17.53% short of its 52-week high of $31.54, which the company reached on July 30th.

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...